INTRODUCTION
degree of viremia. Indeed, HBV DNA levels have been found to decline in serum following the development of The hepatitis B virus (HBV) is the prototype member an immune response to HBeAg (anti-HBe) (Carman and of the hepadnavirus family (McLachlan, 1991) . HBV is a Thomas, 1993) . major cause of acute and chronic hepatitis and persistent
It is now recognized that chronic HBV infection is assoinfection is often associated with the development of liver ciated with the emergence of mutations throughout the cirrhosis and hepatocellular carcinoma (Lau and Wright, viral genome that result in the generation of diverse viral 1993; Wands and Blum, 1991) . The viral genome is made populations or quasispecies. In this regard, viral geof a partially double-stranded 3.2-kb DNA molecule arnomes defective in HBeAg synthesis (HBeAg 0 strains) ranged in a relaxed circular conformation. HBV encodes are frequently found during persistent viral infection. The four partially overlapping open reading frames (ORF) desbiological properties of these naturally occurring HBV ignated as precore/core, polymerase, preS/s, and X. The mutants is controversial. They have been linked to fulmiprecore gene product is a 25-kDa protein that contains nant hepatitis and associated with high levels of viral at the amino terminus a signal peptide sequence that replication (Carman et al., 1991; Liang et al., 1991 ; Omata directs it to the secretory pathway within the cell (Ou et et al., 1991) . Moreover, such viral strains have been found al., 1986). An intermediate 22-kDa protein is produced in individuals with chronic hepatitis B (Brunetto et al., by cleavage of the 19-aa signal peptide and this species 1989; Carman et al., 1989; Naoumov et al., 1992 ; Okamoto is either translocated into the lumen of the endoplasmic et al., 1990; Tong et al., 1990) . At the molecular level, the reticulum or released back into the cytoplasm (Garcia et most prevalent mutation described is a transition from al., 1988). The translocated p22 protein is further pro-TGG to TAG that introduces an amber termination signal cessed at the carboxy terminus to generate a 17-kDa at codon 28 in the precore ORF. Some studies have resoluble monomeric product that is secreted from the cell ported that these mutations result in increased levels of as the HBeAg (Standring, 1991) . HBeAg is found in serum viral replication (Lamberts et al., 1993; , during active infection and generally correlates with the 1997); however, no effects on HBV DNA synthesis have been reported in other studies (Yuan et al., 1995; Hase- core ORF (Okamoto et al., 1994; Sato et al., 1995;  Laskus fragment from pC*28 into payw1.2. This plasmid has the stop codon at position 28 in the precore ORF and the other et al., 1995; Baumert et al., 1996) . The most frequent mutations involve an A-to-T and a G-to-A exchange at aforementioned precore/core ORF mutations but contains a wild-type precore and core promoter sequence. The paynucleotides (nts) 1760 and 1762 in the precore promoter. A liver-enriched transcription factor has been found to wOM construct was generated by introducing an AatIIFspI fragment derived from pC*28 into payw1.2. Therefore, bind to this region of the precore promoter (Guo et al., 1993; Zhang and McLachlan, 1994) . A recent study demthis construct has 12 nucleotide substitutions upstream of and including the precore promoter mutations with the seonstrated that a HBV genome carrying the mutations at nts 1760 and 1762 displayed reduced levels of HBeAg quence ATGAT (nts 1759-1763) but contains the wild-type HBV precore/core genes. The plasmid paywXB was obsynthesis in vitro and was associated with enhanced viral replication (Buckwold et al., 1996) . It has been retained by introducing an XbaI-BspEI (nts 1988-2327) fragment obtained from pC*28 into the payw1.2 construct. This ported that another double mutation at nts 1764 and 1766 may affect pregenomic RNA encapsidation, leading to plasmid contains 12 mutations in the core gene. Specific point mutations were created in the wild-type increased levels of viral replication (Baumert et al., 1996) . However, it should be noted that different HBV genotypes HBV of D genotype by site-directed mutagenesis (pAlter system, Promega Corp.). In this regard, the paywOMPM have been studied and some of the differences found in viral replication may be the result of mutations in other carries the double mutation of A to T and G to A at nts 1760 and 1762, respectively. The pawyFHPM carries a double regions of the viral genome. In the present report, we investigated the functional consequences of introducing mutation of C to T and of T to A at nts 1764 and 1766 in the precore promoter sequence. These mutations have been mutations in the precore promoter/precore gene of a ''wild-type'' HBV genome (Galibert et al., 1979) characterproposed to be important in the generation of a fulminant hepatitis B viral strain (Baumert et al., 1996) . The ized as the D genotype (Norder et al., 1994) . The biologic effects of these mutations were assessed with respect to payw*28PM carries the nonsense TGG to TAG mutation that introduces a stop codon in the precore ORF at codon viral replication, antigen secretion, viral mRNA synthesis, and pregenomic RNA encapsidation.
28. In addition, the plasmid pCMVHBV*28PM was generated to carry the nonsense TGG to TAG mutation into the pCMVHBV vector that expresses the pregenomic RNA un-MATERIALS AND METHODS der the control of the CMV IE promoter (Fallows and Goff, Plasmid constructs 1995). This construct was designed as pCMVHBV*28PM. The pZeroDB plasmid was prepared by cloning the DraIThe plasmid vectors used in this study are depicted in Fig. 1 . All constructs were derived from the previously BglII (nts 1720-1982) HBV insert into the EcoRV-BamHI sites of the pZero-2.1 polylinker (Invitrogen, San Diego, CA). described payw1.2 plasmid (Scaglioni et al., 1997) . This construct consists of a more-than-one HBV-genomeThe correct design of the plasmids was assessed by restriction enzyme mapping and by direct DNA sequencing. length sequence of genotype D (Galibert et al., 1979; Norder et al., 1994) from nts 1411 to 2327 (where nt 1 is
The restriction enzymes were purchased from New England Biolabs (Beverly, MA). Sequence reactions were carby convention located at the GAATTC of the unique EcoRI site) and has been cloned into the AatII and SmaI sites ried out with the Sequenase Version 2.0 enzyme (U.S. Biochemicals, Cleveland, OH). Plasmids were grown in JM109 of the pGEM7 Zf(/) vector (Promega Corp., Madison, WI). The HBV RNA transcripts are expressed under the Escherichia coli cells and purified by a commercially available kit using the manufacturer's instructions (Wizard maxicontrol of endogenous viral regulatory sequences.
The construct payw*28AB has a 0.9-kb AatII-BspEI fragprep kit; Promega Corp.). ment insert from the pC*28 plasmid. The pC*28 construct contains a dimer of a HBV DNA derived from serum of an Tissue culture individual with a naturally occurring HBeAg 0 mutant HBV infection (Tong et al., 1992) . This mutant carries the TGG The HepG2 and HuH-7 cell lines were transiently transfected by means of the calcium phosphate method to TAG nonsense mutation which introduces a termination codon in the precore ORF at codon 28. In addition, this (CaPO 4 transfection Kit, 5-3, Inc., Boulder, CO) with 10 mg of plasmid expressing wild-type or mutant HBV DNA. DNA fragment also carries 12 other nucleotide substitutions upstream of and including the precore promoter and other
The transfection procedure and maintenance of these cell lines in tissue culture have been previously de-21 mutations in the precore/core ORF. In particular, this HBV carries the mutated sequence ATGAT (nts 1759 ATGAT (nts -1763 scribed (Scaglioni et al., 1994) . Transfection efficiency was monitored by adding 1 mg of pCMV luciferase con-(wild-type D genotype is AAGGT) that has been described in naturally occurring HBV mutants either alone or in combistruct, and approximately 1/100 of the cell lysate was subjected to a luciferase assay (Ausubel et al., 1989) . nation with the stop codon mutation in the precore ORF at codon 28 (Okamoto et al., 1994) . The plasmid paywFB was Experiments were discharged if luciferase activity varied more than 20% between the cell lysates derived from generated by exchanging the FspI-BspEI (nts 1798-2327)
Genetic organization of the plasmids used in the study. The payw1.2 construct contains a more-than-one-genome-length sequence that expresses HBV RNAs under the control of the endogenous promoters. The core promoter region is depicted as a shorter box whereas the precore and core ORFs are represented by taller boxes. The payw*28AB, paywFB, paywOM, and paywXB constructs were generated by cassette exchange (as depicted by the shaded boxes) of a naturally occurring HBV mutant carrying mutations in the precore promoter (as represented by black dots) and the amber termination signal at codon position 28 in the precore ORF (asterisk). The plasmids payw*28PM, paywOMPM, and paywFHPM were prepared by site-directed mutagenesis as described under Materials and Methods. The pCMVHBV construct expresses the pregenomic RNA under the control of CMV IE promoter. The pCMVHBV*28 carries a single nucleotide substitution that introduces the amber stop codon mutation in position 28 of the precore gene. The arrows indicate the positions of introduced mutations in the precore promoter.
transfected cells. The quantity of sample to be analyzed Measurement of viral antigens was adjusted according to the level of luciferase activity.
The presence of HBV antigens was measured in the Moreover, the HBsAg concentration was measured in supernatant of cells 5 days after transient transfection the culture supernatant and was used as a second indewith wild-type and mutant viral genomes. The HBeAg pendent assay to determine transfection efficiency. Every assay was performed using a specific radioimmunoastransfection experiment was repeated at least three say (RIA) kit (EBK 125 I RIA KIT, Incstar Corp., Stillwater, times with two different plasmid preparations to ensure MN). It should be emphasized that the monoclonal antireproducibility of the results. Following transfection of body used in this kit is specific for HBeAg and does not cells, viral RNA and DNA was extracted at 2 and 5 days, cross-react with the HBV core protein. Measurement of respectively.
HBsAg in the cell culture supernatants was performed Analysis of viral replication using a radioimmunometric assay as previously described (Melegari et al., 1994) . All measurements were Levels of DNA replication were determined by Southperformed in the linear range of the assay so as to obtain ern blot analysis. HBV DNA was extracted from purified quantitative results. core particles following transient transfection as described (Pugh et al., 1988) . Prehybridization, hybridization, and washing of the Southern blots were performed
Western blot analysis as previously described . The
Western blot analysis of lysates derived from tranbands on the gels were analyzed with a PhosphoImager siently transfected cells was performed as described system and the results obtained from at least three inde- (Scaglioni et al., 1997) . HBV core protein was revealed pendent experiments were averaged (Molecular Imaging by polyclonal rabbit anti-core antiserum (Dako Co., CarSystem, Model GS-363, Bio-Rad Laboratories, Inc., Hercules, CA).
pinteria, CA).
Extraction and analysis of viral RNA
Total RNA was extracted 2 days after transient transfection as previously described (Scaglioni et al., 1994) . Core particles derived from the cytoplasm of transfected cells were immunoprecipitated by a rabbit polyclonal anti-core antibody (Dako Corp.), followed by protein ASepharose precipitation. A digestion with 16 U of RNasefree RQ1 DNase was carried out on the pelleted beads followed by an additional wash in the presence of 50 mM EDTA. After these procedures the encapsidated viral RNA was extracted as described (Scaglioni et al., 1994) .
A RNase protection assay was performed on encapsidated viral RNA using a commercially available kit (RPA II-Ribonuclease protection kit, Ambion Inc., Austin, TX). The viral-specific RNA probe was obtained by incubation of the XhoI linearized pZeroDB with SP6 polymerase (Promega Corp.) in the presence of [a-32 P]UTP (100 mCi at 3000 Ci/mmol, New England Nuclear, Boston, MA) as described (Ausubel et al., 1989) . The resulting RNA probe contains a 262-nt specific antisense HBV sequence and a 57-nt plasmid sequence that will not be protected by digestion after hybridization with the HBV RNAs. This probe is predicted to protect from RNase digestion two segments of the pregenomic RNA: a 166-and a 200-nt species located at the 3 and 5 ends, respectively, of the terminally redundant region of the pregenomic RNA (Nassal et al., 1990; McLachlan, 1991) . Hybridizations 
RESULTS

HBV genomes carrying naturally occurring mutations
containing the mutations were exchanged into the parenin the precore promoter and precore gene display an tal payw1.2 wild-type construct. The paywFB construct enhanced replication phenotype also exhibited a similar high-replication phenotype as compared to the payw*28AB genome (Fig. 2) , while the Increased levels of HBV replication were observed in HCC cells transiently transfected with a more-than-onepaywOM construct exhibited an average twofold increase in the level of replication when compared to the wild-type HBV-genome-length vector containing naturally occurring mutations in the precore promoter and the precore gene.
payw1.2 HBV. The paywXB construct contains mutations only in the central portion of the core gene. Transient Figure 2 shows a representative experiment. Southern blot analysis of purified HBV core particles demonstrated that transfection experiments demonstrated that the paywXB displays very similar replication levels to wild-type transfection of payw*28AB in HuH-7 cells resulted in a fivefold increase (average of three experiments) in HBV payw1.2 (Fig. 2) . Transfection experiments were performed in both HepG2 and HuH-7 HCC cell lines to ex-DNA replicative forms as compared to the wild-type payw1.2 construct (Fig. 2) . To characterize the specific clude the possibility that the differences in viral replication were related to cell type and similar results were obtained mutation(s) responsible for this high-replication phenotype, smaller fragments of the AatII-BspEI DNA insert with both cell lines (data not shown).
mutations in the wild-type payw1.2 HBV genome closely resembled the findings described above with the naturally occurring viral mutants.
We also compared the pattern of HBV replication of paywFHPM to wild-type payw1.2. This plasmid was engineered to contain a double-nucleotide substitution in the precore promoter region that has been recently described as important in conferring a high-replication phenotype in a ''fulminant'' hepatitis B viral strain (Baumert et al., 1996) . This construct directed the synthesis of a twofold (average of three experiments) increase of viral replicative forms as compared to wild-type payw1.2. However, the levels are much lower than those found with payw*28PM (Fig. 3) . To ascertain that the introduction of the nonsense mutation resulting in a stop codon at position 28 of the precore gene did not affect the encapsidation efficiency and DNA priming of the pregenomic RNA, this same mutation was introduced into the pCMVHBV construct. This plasmid does not express precore mRNA and as a consequence does not synthesize HBeAg. The pCMVHBV and pCMVHBV*28 exhibited similar levels of HBV replication following transfection into HuH-7 cells (Fig. 3) .
Effect of the mutations in the precore promoter and precore ORF on viral antigen production in cell culture supernatant derived from transfected HepG2 cells and reduced fourfold following transfection of HuH-7 cells as compared to the levels observed with A stop codon in the precore ORF generates a highwild-type payw1.2 (Fig. 4) . HBeAg was undetectable in replication viral phenotype the culture supernatant of HuH-7 cells transfected with It was necessary to confirm that the above-described pCMVHBV (Figs. 3 and 4) . Finally, we found that the viral mutations were directly responsible for the high-replicastrains carrying the precore promoter and precore mutation phenotype. Therefore, we introduced defined nucleotions expressed similar levels of intracellular p21 core tide substitutions by site-directed mutagenesis. We protein (data not shown). found that payw*28PM exhibited a 5-fold increase (average of three experiments) in the level of viral replication Precore promoter and precore ORF mutations result compared to the wild-type payw1.2 (Fig. 3) . In addition, in increased levels of encapsidated pregenomic RNA the plasmid aywFB showed a similar replication capacity as represented by a 3.5-fold increase in viral replication
We determined if precore promoter and precore ORF mutations affect viral gene expression. Northern blot analyillustrated in Fig. 3 . In contrast, paywOMPM displayed only a 2-fold increase in viral replication. Therefore, the sis performed on total cellular RNA revealed no differences in viral gene expression between wild-type payw1.2 and phenotype exhibited by these artificially created point a fivefold increase in HBV DNA synthesis was associated with a mutant viral strain that contains a precore stop codon mutation at position 28 whereas a twofold increase in HBV DNA replication was found to be associated with specific mutations in the precore promoter region. To confirm that either one of these naturally occurring mutations was responsible for a high-replication phenotype, we engineered the same mutations by sitedirected mutagenesis into the wild-type HBV as well.
First, the biologic consequences of these mutations on expression of HBV antigens were explored. It was found that the precore promoter mutation reduced HBeAg synthesis to about 30% in HepG2 and 20% in HuH-7 cells as compared to levels produced by wildtype HBV. There was no effect of these mutations on HBsAg secretion or on the intracellular levels of HBV core protein. As expected, the precore stop codon mutation at position 28 abolished HBeAg synthesis but did not affect the synthesis of pregenomic RNA. These observations demonstrate that the precore promoter and precore gene mutations do not alter the expression of other HBV genes. Our results are in general agreement mutant viral genomes that could account for the observed differences in the HBV DNA synthesis (Fig. 5A) . We then asked whether the differences in replication phenotype of HBV mutants are due to the levels of core particles containing encapsidated pregenomic RNA. The RNase protection assay revealed that the levels of encapsidated pregenomic RNA were fivefold higher in cells transfected with payw*28PM as compared to wild-type payw1.2. In contrast, the levels of encapsidated pregenomic RNA in core particles were increased twofold in cells transfected with the paywOMPM construct containing the precore promoter mutations (Fig. 5B) .
DISCUSSION
In this report, we evaluated the biological properties to an enhanced viral replication phenotype. For example, al., 1996) . Such studies are consistent with a recent obconfer a different phenotype such as that observed with the fulminant hepatitis B mutant strain described by servation indicating that the promoter elements used in the synthesis of the precore and pregenomic RNAs are Baumert et al. (1996) . In their experiments with a genotype A virus, the precore promoter mutations appeared genetically distinct and separately regulated (Yu and Mertz, 1996) .
to produce a high-replication phenotype whereas in our experiments with a genotype D virus the same mutations Although the amount of pregenomic RNA present in the cytoplasm was unchanged when comparing the levled to only a twofold increase in viral replication. However, in both viral strains, the trend toward a higher repliels produced by wild-type and mutant viruses, the concentration of pregenomic RNA encapsidated into core cation phenotype was observed with these precore promoter mutations. particles was increased fivefold in the payw*28PM construct that contains the precore stop codon and only
The enhanced replication exhibited by the mutant virus containing the precore stop codon mutation at position twofold in the paywOMPM construct that contains the precore promoter mutations. To rule out the possibility 28 described in the present investigation may have important biologic consequences in vivo. The increased that the TGG to TAG transition that introduced the stop codon at position 28 in the precore ORF was responsible level of viral replicative forms may lead to accumulation of viral antigens within infected hepatocytes and promote for increasing the encapsidation efficiency of the pregenomic RNA, the same mutation was introduced into liver injury through an enhanced host immune response (Chisari and Ferrari, 1995) . Increased levels of mutant pCMVHBV, a plasmid that expresses an authentic pregenomic RNA but does not synthesize any precore RNA viral replicative forms may lead to accumulation of cccDNA in the nucleus and result in increased cellular species (Fallows and Goff, 1994) . Our finding indicating that this plasmid does not synthesize any detectable cytopathic effects as well (Lenhoff and Summers, 1994) . Finally, in vitro and in vivo studies with well-defined mutaHBeAg following transient transfection in HuH7 and HepG2 cells suggests that the transfected DNA is the tions in HBV strains of known genotype will be required to assess the potential pathogenic role of alterations in major template for viral transcription in this tissue culture system and not covalently closed circular HBV DNA precore promoter, precore, and preS gene regions with respect to their effects on viral replication either alone (cccDNA). Indeed, under these experimental conditions, there was no increase in HBV replicative forms, indicator in combination. ing that the stop codon mutation did not alter the encapsidation efficiency of the pregenomic RNA (Nassal et al., ACKNOWLEDGMENTS 1990; Tong et al., 1992) or the DNA priming activity of been shown that the expression of the precore protein can suppress HBV replication both in transfected HCC cells and in a HBV transgenic mouse model (Lamberts REFERENCES et al., 1993; Guidotti et al., 1996; Scaglioni et al., 1997) . the Asian Pacific region. It is of interest that in these Brunetto, M. R., Stemmler, M., Schodel, F., Will, H., Ottobrelli, A., Rizareas of the world, the most frequent HBV strain is the zetto, M., Verme, G., and Bonino, F. (1989) . Identification of HBV D genotype, which is prone to develop the precore stop variants which cannot produce precore-derived HBeAg and may be responsible for severe hepatitis. Ital. J. Gastroenterol. 21, [151] [152] [153] [154] codon mutation at position 28. In the rest of Europe and Buckwold, V. E., Xu, Z., Chen, M., Yen, T. S. B., and Ou, J. H. (1996) .
the United States, the HBV A genotype is the most promiEffects of a naturally occurring mutation in the hepatitis B virus basal nent viral strain and it appears that this viral species core promoter on precore gene expression and viral replication. J.
rarely develops the precore stop codon at position 28
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because such a mutation appears to disrupt the viral Carman, W. F., Jacyna, M. R., Hadziyannis, S., Karayiannis, P., McGarvey, M. J., Mekris, A., and Thomas, H. C. (1989) . Mutation preventing encapsidation signal (Li et al., 1993) . 
